Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology
- PMID: 9213215
Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology
Abstract
The glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) appeared to be an archtypical protein of limited excitement. However, independent studies from a number of different laboratories reported a variety of diverse biological properties of the GAPDH protein. As a membrane protein, GAPDH functions in endocytosis; in the cytoplasm, it is involved in the translational control of gene expression; in the nucleus, it functions in nuclear tRNA export, in DNA replication, and in DNA repair. The intracellular localization of GAPDH may be dependent on the proliferative state of the cell. Recent studies identified a role for GAPDH in neuronal apoptosis. GAPDH gene expression was specifically increased during programmed neuronal cell death. Transfection of neuronal cells with antisense GAPDH sequences inhibited apoptosis. Lastly, GAPDH may be directly involved in the cellular phenotype of human neurodegenerative disorders, especially those characterized at the molecular level by the expansion of CAG repeats. In this review, the current status of ongoing GAPDH studies are described (with the exception of its unique oxidative modification by nitric oxide). Consideration of future directions are suggested.
Similar articles
-
Protein thiol modification of glyceraldehyde-3-phosphate dehydrogenase as a target for nitric oxide signaling.Genet Eng (N Y). 1995;17:149-64. Genet Eng (N Y). 1995. PMID: 7540026 Review.
-
New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells.J Cell Biochem. 2005 May 1;95(1):45-52. doi: 10.1002/jcb.20399. J Cell Biochem. 2005. PMID: 15770658 Review.
-
Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs.Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):291-301. doi: 10.1016/S0278-5846(03)00024-1. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12657368 Review.
-
Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts.J Neurosci Res. 2003 Jan 15;71(2):279-85. doi: 10.1002/jnr.10484. J Neurosci Res. 2003. PMID: 12503091
-
Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions.Biochem J. 2009 Sep 25;423(2):253-64. doi: 10.1042/BJ20090854. Biochem J. 2009. PMID: 19650766
Cited by
-
Evolution of the genetic code by incorporation of amino acids that improved or changed protein function.J Mol Evol. 2013 Oct;77(4):134-58. doi: 10.1007/s00239-013-9567-y. Epub 2013 Jun 7. J Mol Evol. 2013. PMID: 23743924
-
Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection.Retrovirology. 2012 Dec 13;9:107. doi: 10.1186/1742-4690-9-107. Retrovirology. 2012. PMID: 23237566 Free PMC article.
-
Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro.J Virol. 2000 Apr;74(8):3634-41. doi: 10.1128/jvi.74.8.3634-3641.2000. J Virol. 2000. PMID: 10729139 Free PMC article.
-
Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12614-8. doi: 10.1073/pnas.95.21.12614. Proc Natl Acad Sci U S A. 1998. PMID: 9770534 Free PMC article.
-
Plasma and Serum Proteins Bound to Nanoceria: Insights into Pathways by which Nanoceria may Exert Its Beneficial and Deleterious Effects In Vivo.J Nanomed Nanotechnol. 2020;11(4):546. Epub 2020 Jul 17. J Nanomed Nanotechnol. 2020. PMID: 34589268 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials